Studies have found that serum antibodies against MAA-modified proteins are associated with active and chronic stages of atherosclerosis in humans [13] and that there are detectable levels of anti-MAA antibody even during the development and progression of atherosclerosis [13–15]. The gene discussed is NAA10; the disease is atherosclerosis.